Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|July 1, 1996
Evaluation of biotechnology productsJ Tami, R P Evens
Biotechniques|January 1, 1996
Cloning of size-selected human immunoglobulin heavy-chain rearrangements from third complementarity-determining region fingerprint profilesF M Raaphorst, J Tami, I E Sanz
International Immunology|November 14, 1997
Human Ig heavy chain CDR3 regions in adult bone marrow pre-B cells display an adult phenotype of diversity: evidence for structural selection of DH amino acid sequencesF M Raaphorst, C S Raman, J Tami, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2000
Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial librariesE Rey, M Zeidel, C Rhine, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2002
Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's diseaseB R Yacyshyn, C Barish, J Goff, et al.
Gut|June 22, 2002
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's diseaseB R Yacyshyn, W Y Chey, J Goff, et al.
Journal of Neuroscience Research|August 15, 1996
Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravisA J Infante, P D Infante, C E Jackson, et al.
Pageof 1